Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 26 , ISSUE 4 ( April, 2022 ) > List of Articles

EDITORIAL

Necrotizing Soft Tissue Infections: More than What Meets the Eye

Keywords : Necrotizing fasciitis, Outcomes, Skin and soft tissue infections

Citation Information : Necrotizing Soft Tissue Infections: More than What Meets the Eye. Indian J Crit Care Med 2022; 26 (4):413-415.

DOI: 10.5005/jp-journals-10071-24196

License: CC BY-NC 4.0

Published Online: 13-05-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

HTML PDF Share
  1. Stevens DL, Bryant AE. Necrotizing soft-tissue infections. Longo DL, editor. N Engl J Med 2017;377(23):2253–2265. DOI: 10.1056/NEJMra1600673.
  2. Kurian P, Korula PJ, Jacob JM, Desha AMK, Karuppusami R. Patient characteristics and outcomes in necrotizing softtissue infections: results from a prospective cohort study in a tertiary care center intensive care unit in South India. Indian J Crit Care Med 2021. DOI: 10.5005/jp-journals-10071-24153.
  3. Khanna AK, Tiwary SK, Kumar P, Khanna R, Khanna A. A case series describing 118 patients with lower limb necrotizing fasciitis. Int J Low Extrem Wounds 2009;8(2):112–116. DOI: 10.1177/1534734609334809.
  4. Madsen MB, Skrede S, Perner A, Arnell P, Nekludov M, Bruun T, et al. Patient's characteristics and outcomes in necrotising soft-tissue infections: results from a Scandinavian, multicentre, prospective cohort study. Intensive Care Med 2019;45(9):1241–1251. DOI: 10.1007/s00134-019-05730-x.
  5. Zhao J-C, Zhang B-R, Shi K, Zhang X, Xie C-H, Wang J, et al. Necrotizing soft tissue infection: clinical characteristics and outcomes at a reconstructive center in Jilin Province. BMC Infect Dis 2017;17(1):792. DOI: 10.1186/s12879-017-2907-6.
  6. Wong C-H, Chang H-C, Pasupathy S, Khin L-W, Tan J-L, Low C-O. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am 2003;85(8): 1454–1460. PMID: 12925624.
  7. Alayed KA, Tan C, Daneman N. Red flags for necrotizing fasciitis: a case control study. Int J Infect Dis 2015;36:15–20. DOI: 10.1016/j.ijid.2015.04.021.
  8. Wong C-H, Khin L-W, Heng K-S, Tan K-C, Low C-O. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med 2004;32(7):1535–1541. DOI: 10.1097/01.ccm.0000129486.35458.7d.
  9. Zacharias N, Velmahos GC, Salama A, Alam HB, de Moya M, King DR, et al. Diagnosis of necrotizing soft tissue infections by computed tomography. Arch Surg 2010;145(5):452–455. DOI: 10.1001/archsurg.2010.50.
  10. Sartelli M, Guirao X, Hardcastle TC, Kluger Y, Boermeester MA, Raşa K, et al. 2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections. World J Emerg Surg 2018;13(1):58. DOI: 10.1186/s13017-018-0219-9.
  11. Mok MY, Wong SY, Chan TM, Tang WM, Wong WS, Lau CS. Necrotizing fasciitis in rheumatic diseases. Lupus 2006;15(6):380–383. DOI: 10.1191/0961203306lu2314cr.
  12. Mouës CM, van den Bemd GJCM, Heule F, Hovius SER. Comparing conventional gauze therapy to vacuum-assisted closure wound therapy: a prospective randomised trial. J Plast Reconstr Aesthet Surg 2007;60(6):672–681. DOI: 10.1016/j.bjps.2006.01.041.
  13. Darenberg J, Luca-Harari B, Jasir A, Sandgren A, Pettersson H, Schalén C, et al. Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis 2007;45(4):450–458. DOI: 10.1086/519936.
  14. Anaya DA, McMahon K, Nathens AB, Sullivan SR, Foy H, Bulger E. Predictors of mortality and limb loss in necrotizing soft tissue infections. Arch Surg 2005;140(2):151–157; discussion 158. DOI: 10.1001/archsurg.140.2.151.
  15. Huang K-F, Hung M-H, Lin Y-S, Lu C-L, Liu C, Chen C-C, et al. Independent predictors of mortality for necrotizing fasciitis: a retrospective analysis in a single institution. J Trauma 2011;71(2): 467–473; discussion 473. DOI: 10.1097/TA.0b013e318220d7fa.
  16. Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 2014;370(15):1412–1421. DOI: 10.1056/NEJMoa1305727.
  17. Kurian GP, Korula PJ, Jacob JM, Desha AMK, Karuppusami R, Kandasamy S. Patient Characteristics and Outcomes in Necrotizing Soft-tissue Infections: Results from a Prospective Cohort Study in a Tertiary Care Center Intensive Care Unit in South India. Indian J Crit Care Med 2022;26(4):452–456.
  18. Darenberg J, Ihendyane N, Sjölin J, Aufwerber E, Haidl S, Follin P, et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2003;37(3):333–340. DOI: 10.1086/376630.
  19. Kaul R, McGeer A, Norrby-Teglund A, Kotb M, Schwartz B, O'Rourke K, et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome–a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis 1999;28(4):800–807. DOI: 10.1086/515199.
  20. Soh CR, Pietrobon R, Freiberger JJ, Chew ST, Rajgor D, Gandhi M, et al. Hyperbaric oxygen therapy in necrotising soft tissue infections: a study of patients in the United States Nationwide Inpatient Sample. Intensive Care Med 2012;38(7):1143–1151. DOI: 10.1007/s00134-012-2558-4.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.